Variant Bio Launches World's First Agentic AI Genomic Drug Discovery Platform
The agentic AI platform by Variant Bio, named Inference, brings together genetic and multi-omic data with autonomous analysis capabilities, and is already powering pharmaceutical partnerships totaling over USD 200 million.
Agentic AI | 09/01/2026 | By News Bureau | 349
Qure.ai Partners with Microsoft to Expand Lung Cancer AI Access in the US
Qure.ai has partnered with Microsoft to broaden access to its advanced lung cancer detection and management AI suite across the US. The collaboration integrates Qure.ai’s LLM- and agentic AI–driven tools into clinical workflows, helping radiology and pulmonology teams accelerate patient detection, diagnosis, and treatment pathways.
Agentic AI | 20/11/2025 | By Dineshwori | 221
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy